T1	CHEM 80 86	renina
#1	AnnotatorNotes T1	C0035094; Renin; Amino Acid, Peptide, or Protein · Enzyme
T2	CHEM 87 99	angiotensina
#2	AnnotatorNotes T2	C0003018; Angiotensins; Amino Acid, Peptide, or Protein · Biologically Active Substance · Pharmacologic Substance
T3	ANAT 143 154	ventricular
#3	AnnotatorNotes T3	C0018827; Heart Ventricle; Body Part, Organ, or Organ Component | C1280934; Entire cardiac ventricle; Body Part, Organ, or Organ Component
T4	ANAT 201 208	aórtica
#4	AnnotatorNotes T4	C0003501; Aortic valve structure; Body Part, Organ, or Organ Component | C1269005; Entire aortic valve; Body Part, Organ, or Organ Component
T5	DISO 232 249	Estenosis aórtica
#5	AnnotatorNotes T5	C0003507; Aortic Valve Stenosis; Disease or Syndrome
T6	PROC 506 567	Sustitución de la válvula aórtica con una prótesis percutánea
T7	PROC 374 389	hospitalización
#6	AnnotatorNotes T7	C0019993; Hospitalization; Health Care Activity
T8	PROC 430 441	diagnóstico
#7	AnnotatorNotes T8	C0011900; Diagnosis; Diagnostic Procedure
T9	DISO 445 462	estenosis aórtica
#8	AnnotatorNotes T9	C0003507; Aortic Valve Stenosis; Disease or Syndrome
T10	PROC 484 501	ecocardiográficos
#9	AnnotatorNotes T10	C0013516; Echocardiography; Diagnostic Procedure
T11	ANAT 524 539	válvula aórtica
#10	AnnotatorNotes T11	C0003501; Aortic valve structure; Body Part, Organ, or Organ Component | C1269005; Entire aortic valve; Body Part, Organ, or Organ Component
T12	DISO 613 630	estenosis aórtica
#11	AnnotatorNotes T12	C0003507; Aortic Valve Stenosis; Disease or Syndrome
T13	PROC 688 690	RM
#12	AnnotatorNotes T13	C0024485; Magnetic Resonance Imaging; Diagnostic Procedure
T14	DISO 835 854	Valvulopatía mitral
T15	ANAT 848 854	mitral
#13	AnnotatorNotes T15	C0026264; Mitral Valve; Body Part, Organ, or Organ Component | C1269004; Entire mitral valve; Body Part, Organ, or Organ Component
T16	PROC 877 889	intervención
#14	AnnotatorNotes T16	C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T17	PROC 893 935	Fracción de eyección ventricular izquierda
T18	CHEM 1056 1075	bloqueantes del SRA
T19	DISO 968 988	infarto de miocardio
#15	AnnotatorNotes T19	C0027051; Myocardial infarction; Disease or Syndrome | C0155626; Acute myocardial infarction; Disease or Syndrome
T20	PROC 991 1002	diagnóstico
#16	AnnotatorNotes T20	C0011900; Diagnosis; Diagnostic Procedure
T21	DISO 1013 1036	miocardiopatía dilatada
#17	AnnotatorNotes T21	C0007193; Cardiomyopathy, Dilated; Disease or Syndrome
T22	PROC 1040 1052	Prescripción
#18	AnnotatorNotes T22	C0033080; Prescription procedure; Health Care Activity | C2239117; Prescription of drug (procedure); Health Care Activity
T23	ANAT 1072 1075	SRA
#19	AnnotatorNotes T23	C0086907; Renin-Angiotensin-Aldosterone System; Body System
T24	DISO 1126 1133	Alergia
#20	AnnotatorNotes T24	C1527304; Allergic Reaction; Pathologic Function
T25	CHEM 1164 1169	IECAs
#21	AnnotatorNotes T25	C0003015; Angiotensin-Converting Enzyme Inhibitors; Pharmacologic Substance
T26	DISO 1173 1192	Insuficiencia renal
#22	AnnotatorNotes T26	C0035078; Kidney Failure; Disease or Syndrome | C1565489; Renal Insufficiency; Disease or Syndrome
T27	PROC 1208 1227	filtrado glomerular
#23	AnnotatorNotes T27	C0017654; Glomerular Filtration Rate; Diagnostic Procedure
T28	PROC 1353 1370	Presión sistólica
#24	AnnotatorNotes T28	C1306620; Systolic blood pressure measurement; Diagnostic Procedure
T29	CHEM 1326 1335	gadolinio
#25	AnnotatorNotes T29	C0016911; gadolinium; Element, Ion, or Isotope · Indicator, Reagent, or Diagnostic Aid
T30	PROC 1347 1349	RM
#26	AnnotatorNotes T30	C0024485; Magnetic Resonance Imaging; Diagnostic Procedure
T31	PROC 1486 1500	ensayo clínico
#27	AnnotatorNotes T31	C0008976; Clinical Trials; Research Activity
T32	ANAT 72 99	sistema renina-angiotensina
#28	AnnotatorNotes T32	C0035096; Renin-angiotensin system; Body System
T33	PROC 163 208	colocación de una prótesis percutánea aórtica
T34	ANAT 242 249	aórtica
#29	AnnotatorNotes T34	C0003501; Aortic valve structure; Body Part, Organ, or Organ Component | C1269005; Entire aortic valve; Body Part, Organ, or Organ Component
T35	ANAT 455 462	aórtica
#30	AnnotatorNotes T35	C0003501; Aortic valve structure; Body Part, Organ, or Organ Component | C1269005; Entire aortic valve; Body Part, Organ, or Organ Component
T36	PROC 728 752	consentimiento informado
#31	AnnotatorNotes T36	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T37	ANAT 623 630	aórtica
#32	AnnotatorNotes T37	C0003501; Aortic valve structure; Body Part, Organ, or Organ Component | C1269005; Entire aortic valve; Body Part, Organ, or Organ Component
T38	ANAT 914 925	ventricular
#33	AnnotatorNotes T38	C0018827; Heart Ventricle; Body Part, Organ, or Organ Component | C1280934; Entire cardiac ventricle; Body Part, Organ, or Organ Component
T39	DISO 1136 1148	intolerancia
#34	AnnotatorNotes T39	C0277585; Intolerance to drug; Pathologic Function
T40	ANAT 979 988	miocardio
#35	AnnotatorNotes T40	C0027061; Myocardium; Tissue | C1284309; Entire myocardium; Tissue
T41	ANAT 1187 1192	renal
#36	AnnotatorNotes T41	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T42	Date 13 17	2017
T43	DEVI 181 189	prótesis
#37	AnnotatorNotes T43	C0175649; Prosthesis; Medical Device
T44	LIVB 311 320	pacientes
#38	AnnotatorNotes T44	C0030705; Patients; Patient or Disabled Group
T45	Age 321 339	mayores de 60 años
T46	DEVI 548 556	prótesis
#39	AnnotatorNotes T46	C0175649; Prosthesis; Medical Device
T48	Neg_cue 651 657	ningún
T49	DEVI 658 669	dispositivo
#40	AnnotatorNotes T49	C1285539; Direct device; Medical Device
T51	PHYS 707 715	entender
#41	AnnotatorNotes T51	C0162340; Comprehension; Mental Process
T53	Duration 1079 1090	los 3 meses
T60	Neg_cue 1304 1306	no
T62	PROC 1353 1360;1391 1401	Presión diastólica
#42	AnnotatorNotes T62	C1305849; Diastolic blood pressure measurement; Diagnostic Procedure
T63	PHYS 1422 1430	Embarazo
#43	AnnotatorNotes T63	C0032961; Pregnancy; Organism Function
T64	Date 1434 1460	segundo o tercer trimestre
T66	PHYS 905 935	eyección ventricular izquierda
#44	AnnotatorNotes T66	C2733342; Left ventricular ejection; Physiologic Function
T47	PHYS 132 154	remodelado ventricular
#45	AnnotatorNotes T47	C0600519; Ventricular Remodeling; Organ or Tissue Function
T50	ANAT 1217 1227	glomerular
#46	AnnotatorNotes T50	C0022663; Kidney Glomerulus; Body Part, Organ, or Organ Component | C1284485; Entire glomerulus; Body Part, Organ, or Organ Component
T52	PROC 349 359	reclutados
#47	AnnotatorNotes T52	C0242800; Patient Recruitment; Research Activity
A1	Assertion T49 Negated
A2	Assertion T29 Negated
A3	Status T19 History_of
A4	Status T21 History_of
A5	Status T39 History_of
A6	Status T24 History_of
#48	AnnotatorNotes T14	C0026265; Diseases of mitral valve; Disease or Syndrome
#49	AnnotatorNotes T17	C2700377; Measurement of Left Ventricular Ejection Fraction; Diagnostic Procedure
T54	Neg_cue 670 672	no
T55	Quantifier_or_Qualifier 673 683	compatible
A7	Assertion T55 Negated
T56	Neg_cue 767 774	ninguno
T57	CONC 782 804	criterios de exclusión
A8	Assertion T57 Negated
#50	AnnotatorNotes T57	C0680251; Exclusion Criteria; Functional Concept
R1	Location_of Arg1:T15 Arg2:T14	
T58	CONC 109 126	evolución clínica
#51	AnnotatorNotes T58	C0449259; Clinical course; Temporal Concept
R2	Location_of Arg1:T3 Arg2:T47	
R3	After Arg1:T47 Arg2:T33	
R4	After Arg1:T58 Arg2:T33	
R5	Used_for Arg1:T43 Arg2:T33	
R6	Location_of Arg1:T4 Arg2:T33	
R7	Location_of Arg1:T34 Arg2:T5	
T59	Quantifier_or_Qualifier 250 256	severa
#52	AnnotatorNotes T59	C1547227; Severe - Severity of Illness Code; Intellectual Product
R8	Has_Quantifier_or_Qualifier Arg1:T5 Arg2:T59	
R9	Has_Age Arg1:T44 Arg2:T45	
R10	Experiences Arg1:T44 Arg2:T7	
R11	Before Arg1:T7 Arg2:T52	
R12	Experiences Arg1:T44 Arg2:T9	
R13	Location_of Arg1:T35 Arg2:T9	
T61	Quantifier_or_Qualifier 463 469	severa
#53	AnnotatorNotes T61	C1547227; Severe - Severity of Illness Code; Intellectual Product
T65	Quantifier_or_Qualifier 631 637	severa
#54	AnnotatorNotes T65	C1547227; Severe - Severity of Illness Code; Intellectual Product
R14	Has_Quantifier_or_Qualifier Arg1:T12 Arg2:T65	
R15	Location_of Arg1:T37 Arg2:T12	
R16	Has_Quantifier_or_Qualifier Arg1:T9 Arg2:T61	
R18	Before Arg1:T10 Arg2:T8	
R19	Experiences Arg1:T44 Arg2:T10	
R20	Location_of Arg1:T11 Arg2:T6	
R21	Used_for Arg1:T46 Arg2:T6	
R22	Negation Arg1:T48 Arg2:T49	
R23	Negation Arg1:T54 Arg2:T55	
R24	Overlap Arg1:T49 Arg2:T13	
#55	AnnotatorNotes T55	C1524057; Compatible; Qualitative Concept
T67	Observation 694 703	Capacidad
#56	AnnotatorNotes T67	C1299581; Able (finding); Finding (?) | C1555472; Authorized; Finding (?)
R25	Overlap Arg1:T67 Arg2:T51	
R26	Overlap Arg1:T67 Arg2:T36	
R27	Overlap Arg1:T51 Arg2:T36	
R28	Negation Arg1:T56 Arg2:T57	
T68	Observation 1464 1500	Participación en otro ensayo clínico
R29	Overlap Arg1:T63 Arg2:T64	
T69	Result_or_Value 1371 1388	menor de 100 mmHg
R30	Has_Result_or_Value Arg1:T28 Arg2:T69	
T70	Result_or_Value 1402 1418	menor de 40 mmHg
R31	Has_Result_or_Value Arg1:T62 Arg2:T70	
R32	Causes Arg1:T25 Arg2:T39	
R33	Causes Arg1:T25 Arg2:T24	
R34	Before Arg1:T22 Arg2:T18	
R35	Overlap Arg1:T18 Arg2:T53	
T71	CONC 1102 1122	comienzo del estudio
#57	AnnotatorNotes T71	C4684789; Study Start; Temporal Concept
R36	Before Arg1:T18 Arg2:T71	
R37	Location_of Arg1:T38 Arg2:T17	
R38	Location_of Arg1:T38 Arg2:T66	
T72	Result_or_Value 936 949	menor del 40%
R40	Has_Result_or_Value Arg1:T17 Arg2:T72	
R41	Location_of Arg1:T40 Arg2:T19	
R42	Location_of Arg1:T40 Arg2:T21	
T73	Observation 46 55	Beneficio
#58	AnnotatorNotes T73	C4049461; Unexpected beneficial therapeutic response; Finding (?)
R43	After Arg1:T73 Arg2:T33	
R44	Has_Quantifier_or_Qualifier Arg1:T49 Arg2:T55	
R45	Location_of Arg1:T41 Arg2:T26	
T74	Result_or_Value 1228 1239	< 30 ml/min
R46	Has_Result_or_Value Arg1:T27 Arg2:T74	
R47	Location_of Arg1:T50 Arg2:T27	
T75	Quantifier_or_Qualifier 1193 1206	significativa
#59	AnnotatorNotes T75	C1546944; Event Seriousness - Significant; Qualitative Concept
R48	Has_Quantifier_or_Qualifier Arg1:T26 Arg2:T75	
T76	Result_or_Value 1250 1270	entre 30 y 50 ml/min
T77	Observation 1272 1298	puede entrar en el estudio
#60	AnnotatorNotes T77	C1302261; Patient eligible for clinical trial; Finding (?)
R49	Negation Arg1:T60 Arg2:T29	
R50	Before Arg1:T77 Arg2:T29	
R51	Overlap Arg1:T29 Arg2:T30	
R52	Before Arg1:T77 Arg2:T30	
R53	Experiences Arg1:T44 Arg2:T52	
#61	AnnotatorNotes T18	C5240314; Substance with renin-angiotensin system inhibitor mechanism of action (substance); Pharmacologic Substance
A9	Assertion T76 Hypothetical
A10	Experiencer T44 Patient
